Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Fundacio Privada Institut De Recerca Hospital Universitari Vall Hebron (Ir-Huvh) currently manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to examiner ALLEN, MARIANNE P, who is the busiest examiner for the portfolio with 1 pending matter. The data indicates 1 distinct examiner and 1 distinct art unit are involved in the current prosecution. For a practitioner, this narrow focus means that the success of the company's active patenting efforts depends on a single examiner's review. No other examiners or units are currently providing feedback on the company's applications.
With 1 pending office action, the company's active presence at the patent office is quite small. The concentration in 1 distinct art unit allows the practitioner to focus on the specific guidelines of that unit. ALLEN, MARIANNE P is the only examiner currently reviewing the company's pending work, making their individual examination style the primary factor in the prosecution. The Biotechnology & Pharmaceuticals technology area suggests the pending matter involves complex biological or pharmaceutical subject matter. The 1 distinct examiner and 1 distinct art unit structure creates a very streamlined administrative process for this company.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALLEN, MARIANNE P | 1 | 60.1% | +18.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18652603 | THERAPEUTIC AGENTS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH UNDESIRED CELL PROLIFERATION | ALLEN, MARIANNE P | — |
| Art Unit | Apps |
|---|---|
| 1647 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18652603 | THERAPEUTIC AGENTS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH UNDESIRED CELL PROLIFERATION | ALLEN, MARIANNE P | 1647 | §112 | Non-Final OA | — | Pending | May 01, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFundacio Privada Institut De Recerca Hospital Universitari Vall Hebron (Ir-Huvh) has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Marianne P Allen has the most, with 1 of Fundacio Privada Institut De Recerca Hospital Universitari Vall Hebron (Ir-Huvh)'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
